Refer to Data Set ESTROGEN.DAT at www.cengagebrain .com. The...

Refer to Data Set ESTROGEN.DAT at www.cengagebrain .com. The format is in Table 13.49. Three separate two-period cross-over studies were performed, based on different groups of subjects. Study 1 compared 0.625 mg estrogen with placebo. Study 2 compared 1.25 mg estrogen with placebo. Study 3 compared $1.25 \mathrm{mg}$ estrogen with 0.625 mg estrogen. Subjects received treatment for 4 weeks in each active-treatment period; a 2 -week washout period separated the two active-treatment periods. Answer Problem 13.55 for study 2.

Refer to Data Set ESTROGEN.DAT at www.cengagebrain .com. The format is in Table 13.49.
Three separate two-period cross-over studies were performed, based on different groups of subjects. Study 1 compared 0.625 mg estrogen with placebo. Study 2 compared 1.25 mg estrogen with placebo. Study 3 compared $1.25 \mathrm{mg}$ estrogen with 0.625 mg estrogen. Subjects received treatment for 4 weeks in each active-treatment period; a 2 -week washout period separated the two active-treatment periods.
Answer Problem 13.55 for study 2.

Key Concepts

Paired Comparisons

In cross-over studies, paired comparisons involve analyzing the differences in outcomes observed in the same individual under different treatment conditions. This approach takes advantage of within-subject comparisons to improve the precision of treatment effect estimates by reducing inter-subject variability.

Randomization in Clinical Trials

Randomization refers to the process of assigning subjects to different sequences of treatments in a way that each sequence is equally likely. This technique is essential for preventing bias, ensuring that the treatment groups are comparable, and enhancing the internal validity of the study.

Period Effects and Carry-over Effects

Period effects are the changes in the outcome that occur over time independent of the treatment, while carry-over effects are residual effects from a previous treatment that may impact responses in subsequent periods. Assessing and controlling these effects is critical in cross-over studies to ensure that the observed differences between treatments accurately reflect the treatment effects themselves.

Cross-over Study Design

A cross-over study is a type of clinical trial design in which each subject receives multiple treatments (or interventions) over different periods. This design allows each participant to act as their own control, which can reduce variability and increase the efficiency of statistical analysis by directly comparing responses to different treatments within the same individual.

Washout Period

A washout period is an interval between treatment phases in a cross-over trial during which no active treatment is administered. Its purpose is to allow any residual effects of a previous treatment to dissipate, thereby minimizing carry-over effects that could confound the results of subsequent treatment comparisons.

Transcript

Please give Ace some feedback